VALIC Company I Health Sciences Fund (VCHSX)

25.61
Net Asset Value
+1.43%
1 Day
-1.42%
Year-to-Date
Overall Morningstar Rating
Health
Style or Category
No Load
Sales Expenses
1.11%
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital growth. The fund normally invests at least 80% of net assets in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). It can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-cap companies. The fund may invest up to 35% of its total assets in foreign stocks, which include non-dollar denominated securities traded outside the U.S.

Performance

1 month+8.20% 3 years+37.03%
3 months+12.11% 5 years+28.95%
1 year+29.25% Since inception+12.22%
Data through --

Peer Comparisonvs. Health

 VCHSXCategory
Performance 5-yr return+28.95%+21.57%
Expense ratio1.11%1.45%
Risk 5 year sharpe ratio1.781.52
Net assets$848.0M$3.7B
Average market cap$19.5B$35.3B
Average P/E28.126.2
Portfolio turnover59%59%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyVALIC
Fund manager & tenureTaymour Tamaddon / 2 Years
Minimal initial investment$0.00
Minimum IRA investment--

Holdings

U.S. stock84.60%
International stock12.29%
Cash2.36%
Fixed income0.74%
Other0.01%
Top 5 Sectors
Portfolio weighting
Healthcare 93.57%
Consumer service 1.09%
Industrial materials 0.89%
Financial service 0.35%
Hardware 0.19%
Top 10 Holdings
Portfolio weighting
AGN Allergan4.60%
GILD Gilead Sciences4.48%
ALXN Alexion Pharmaceuticals Inc4.43%
AET Aetna3.14%
MCK McKesson Corp3.04%
UNH UnitedHealth3.02%
ACT Actavis2.94%
-- 2.82%
BIIB Biogen2.45%
DHR Danaher Corp2.30%

To view my watchlist

Not a member yet?

Sign up now for a free account